FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
Whitepaper

Embedded banking but not as you know it

Admin May 12, 2026 0
Articles

How Smart Money Management and Digital Trends Are Reshaping Wealth in…

Whitepaper

INVESTMENT GUIDE Investing for your future

Whitepaper

5 Approaches to Scaling Finance Accuracy with AI

Whitepaper

Understanding the Financial Interest Clause

Articles

Traders with High Frequency: Experts in Contemporary Financial Markets

Admin Mar 9, 2026
High Frequency Traders (HFT) operate in a high-speed environment, aiming to capture small profits through…
Articles

Bloomberg Introduces New Financial Instrument Global Identifier (FIGI) Mapping…

Admin Mar 6, 2026
In order to give exchanges, data providers, custodians, and other organizations direct access to a variety of…
Whitepaper

For the Capital Markets, Every Risk Playbook Needs to Implement These 6 Themes

Admin Mar 5, 2026
The capital markets have not really benefitted from any tailwinds recently: Inflation rose and is not yet close to…
Whitepaper

Understanding the Financial Interest Clause

Admin Mar 4, 2026
A Financial Interest Clause (FIC) is one of many options available to companies with multinational exposures. Like…
Whitepaper

Why financial institutions need one-to-one messaging to build profitable customer…

Admin Mar 3, 2026
By taking advantage of today’s technologically advanced world, there are many opportunities for financial…
Whitepaper

Challenges and opportunities of the metaverse in financial services

Admin Mar 2, 2026
Experts agree that the metaverse, from both a technological and a business perspective, still has a long way to go…
Articles

Software for Financial Accounting for Effective Management

Admin Feb 27, 2026
One kind of software that assists companies in managing their financial operations is financial accounting…
Featured News

Verifying B2B Payments with E-Invoicing: A Way to Ensure Long-Term Development

Admin Feb 26, 2026
For companies of all sizes and in all sectors, the use of electronic invoicing and payments, or "e-invoicing," is…
Articles

How to Establish a Brand with Social Media for Financial Advisors

Admin Feb 25, 2026
Establishing a strong brand presence on social media is essential for financial advisors looking to stand out…
Articles

The Fintech Industry’s Most Valuable Applications of Blockchain

Admin Feb 24, 2026
The decentralized network, protected data, transparent database, and encrypted transactions of blockchain…
Whitepaper

Sovereign Wealth Funds Insights

Admin Feb 23, 2026
With concerns about global economic stability, many sovereign wealth funds (SWFs) are evaluating current market…
Whitepaper

Revolutionizing Instant Payments with MongoDB

Admin Feb 20, 2026
The payment industry is experiencing a revolutionary shift, with traditional transaction timelines reduced from…
Whitepaper

Immersive Banking: A New Paradigm for Customer Engagement in Financial Services

Admin Feb 19, 2026
As immersive technologies evolve primarily powered by investments from big techs like Apple (Apple placing its…
Whitepaper

Building a Better Banking Ecosystem with Modern Network Connectivity

Admin Feb 18, 2026
The technology infrastructure most businesses rely on is rapidly transforming, with the cloud and AI-driven…
Whitepaper

ECMS: a game changer to access your central bank

Admin Feb 17, 2026
Central banks play an important role in ensuring sufficient liquidity is available for financial markets.…
Whitepaper

How Your Personality Is Impacting Your Finances

Admin Feb 16, 2026
Your personality impacts how you make decisions in almost every area of your life. Your career, relationships,…
Whitepaper

Value-Driven Experiences Led by API in Fintech

Admin Feb 13, 2026
As a growing number of consumers and businesses incorporate web and mobile apps into their daily routines,…
Articles

Which financial companies are leading the way in AI?

Admin Feb 12, 2026
Artificial Intelligence (AI) isn’t just a buzzword in the financial world — it’s transforming practically every…
Infographics

Why Investors Should Rethink Traditional Income Strategies

Admin Feb 11, 2026
Today's infographic shows why traditional longer-term bonds are no longer as effective, so which additional income…
Whitepaper

The Future of Private Assets in Retail Investors’ Portfolios

Admin Feb 2, 2026
Asset managers headquartered in Europe saw their private market assets continue to grow, albeit more slowly than…
Whitepaper

Reduce Paper & Costs With AP Automation

Admin Jan 30, 2026
Manual accounts payable (AP) processes are costly, inefficient, and expose companies to unnecessary risk. With the…
Whitepaper

From Enablement to Growth: AI’s Role in Wealth Management Success

Admin Jan 29, 2026
Wealth management firms face new pressures from complex products, higher client expectations, and regulations.…
Whitepaper

FlashSpread cloud: The future of financial analysis

Admin Jan 28, 2026
Spreading tax returns is an essential task in commercial lending. As part of the process of standardizing…
Articles

Credit Score Revolution in 2026: New Guidelines, Benefits, and What Every Borrower…

Admin Jan 23, 2026
In 2026, credit scores are taking center stage in personal finance as regulators, lenders, and scoring…
Articles

Innovation, Regulation, and the Next Frontier of Financial Technology

Admin Jan 22, 2026
The FinTech industry continues to be one of the most dynamic sectors in the global economy as we move deeper…
Featured News

Digital Payments and Embedded Finance Accelerate Financial Inclusion

Admin Jan 21, 2026
The fintech sector continues to disrupt traditional banking models as digital payments and embedded finance…
Whitepaper

Immersive Banking: A New Paradigm for Customer Engagement in Financial Services

Admin Jan 20, 2026
As immersive technologies evolve primarily powered by investments from big techs like Apple (Apple placing its…
Whitepaper

The Future of Claims Management: Why the Human Element Will Always Matter

Admin Jan 19, 2026
Human insight remains irreplaceable in claims management, even as automation and AI revolutionize the industry.…
Featured News

Fintech Innovation and the Redefinition of Financial Services

Admin Jan 16, 2026
Fintech has transformed how individuals and businesses interact with money. From digital payments and mobile…
Whitepaper

Technology-Driven Project Management for Retail Store Development

Admin Jan 15, 2026
Gain practical tools to boost alignment, control costs, and speed store openings across your portfolio. …
Whitepaper

The embedded edge: how financial services win with Cyber Safety”

Admin Jan 14, 2026
Discover how to capture loyalty, reduce churn, and expand revenue in the age of digital risk with this free white…
Whitepaper

Payroll Basics for NZ Employers

Admin Jan 13, 2026
Getting started with payroll in New Zealand? The New Zealand payroll basics factsheet explains what you need to…
Previous 1 2 3 4 … 14 Next

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future
    • 5 Approaches to Scaling Finance Accuracy with AI
    • Understanding the Financial Interest Clause

    ARTICLE

    Ocugen to Participate in Upcoming May Scientific and Investor Conferences
    2026-05-13T11:02:00Z
    MALVERN, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the...


    Andera Partners Leads $20 Million Series D Financing in Rivermark Medical
    2026-05-13T11:00:00Z
    The FloStent™ System Promises to Redefine the BPH Care Pathway


    Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences
    2026-05-13T11:00:00Z
    NORWOOD, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on developing promising new therapies in oncology and obesity, today announced that...


    Nurix Therapeutics to Participate in Upcoming Investor Conferences
    2026-05-13T11:00:00Z
    BRISBANE, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines in...


    Humacyte Announces First Quarter 2026 Financial Results and Provides Business Update
    2026-05-13T11:00:00Z
    - Appointed Jim Mercadante as Chief Commercial Officer and Dr. Todd Rasmussen as Chief Surgical Officer -


    Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference
    2026-05-13T11:00:00Z
    RESEARCH TRIANGLE PARK, N.C., May 13, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision...


    Verano Submits DEA Registration Applications for State-Licensed Medical Cannabis Businesses Following Landmark Federal Rescheduling Order 
    2026-05-13T11:00:00Z
    CHICAGO, May 13, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the Company has submitted...


    BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026
    2026-05-13T11:00:00Z
    RESEARCH TRIANGLE PARK, N.C., May 13, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present new real-world evidence at the 2026 International Society for...


    Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline
    2026-05-13T11:00:00Z
    BOSTON, May 13, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics...


    PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
    2026-05-13T11:00:00Z
    Investor Webcast Scheduled for 8:00 am ET


    Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates
    2026-05-13T11:00:00Z
    WAYNE, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) (“Avalo”), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today...


    BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update
    2026-05-13T11:00:00Z
    AACR 2026 Data Positions Plinabulin as a Potential Backbone Agent to Combine with Antibody-Drug Conjugate (ADC)-Based Therapies to Improve Anti-Cancer Efficacy and Tolerability


    Seer Files Patent Infringement Lawsuit Against Nanomics
    2026-05-13T11:00:00Z
    Seer defends its pioneering Proteograph® Product Suite intellectual property (IP)


    Upstream Bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
    2026-05-13T11:00:00Z
    – Company rapidly advancing Phase 3 programs designed to deliver best-in-class efficacy with convenient quarterly dosing in severe asthma and CRSwNP –


    Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
    2026-05-13T11:00:00Z
    SAN MATEO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that...


    Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy
    2026-05-13T11:00:00Z
    Phase 2b study design to be discussed at BIO International Convention in San Diego as Can-Fite advances partnership negotiations with leading oncology companies


    Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year
    2026-05-13T11:00:00Z
    REHOVOT, Israel, and HOBOKEN, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare...


    Zenas BioPharma Announces First Subject Dosed in Phase 1 Clinical Trial of ZB021, a Novel, Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
    2026-05-13T10:50:00Z
    - Phase 1 trial designed to evaluate the safety, tolerability, and pharmacokinetic properties of ZB021 in healthy volunteers and to establish proof-of-concept in patients with plaque psoriasis -


    Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
    2026-05-13T10:30:00Z
    --Phase 2b PLATEAU clinical study evaluating enobosarm + semaglutide is actively enrolling and on track for interim analysis first quarter calendar year 2027—


    Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
    2026-05-13T10:30:00Z
    DOYLESTOWN, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of...


    Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026
    2026-05-13T10:01:00Z
    - VY1706 IND application process on track for Q2 2026; clinical entry expected H2 2026 -


    Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update
    2026-05-13T10:00:00Z
    – Obexelimab marketing applications for the treatment of IgG4-RD on-target for submission to the FDA this quarter and the EMA in H2 2026 based on the Phase 3 INDIGO IgG4-RD...


    Zymeworks Announces Participation in Upcoming Investor Conferences
    2026-05-13T10:00:00Z
    VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel,...


    NVision Expands from Quantum Sensing to Quantum Computing to Accelerate Discovery and Validation of New Therapies
    2026-05-13T10:00:00Z
    $55 Million Series B to Advance Quantum for Healthcare


    HepaRegeniX to Present Interim Phase 1b Data for Darizmetinib (HRX215) in a Late-Breaking Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2026
    2026-05-13T09:00:00Z
    Tuebingen, Germany, May 13, 2026 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage biotech company advancing novel therapies for acute and chronic liver diseases, announces that its abstract highlighting clinical data for the lead candidate darizmetinib (formerly HRX215) has been selected for a late-breaking oral presentation at the European Association for the Study...


    Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors
    2026-05-13T08:00:00Z
    BASEL, Switzerland, May 13, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage biotechnology company pioneering precision biologics to reprogram the immune system for the treatment of autoimmune and inflammatory diseases, today...


    Inventiva to Present Abstracts at the EASL Congress 2026
    2026-05-13T06:30:00Z
    Daix (France), New York City (New York, United States), May 13, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development...


    Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026
    2026-05-13T06:05:00Z
    SOUTH SAN FRANCISCO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver...


    Fangzhou Showcases “AI+H2H” Chronic Disease Service Innovations at the National Intelligent Medicine Conference
    2026-05-13T06:03:39Z
    WUHAN, China, May 13, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, participated in the 2026 National Medical...


    Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026
    2026-05-13T06:00:00Z
    SOUTH SAN FRANCISCO, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced topline clinical data...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.